chr19-17888430-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000453.3(SLC5A5):​c.1626C>T​(p.Cys542Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.028 in 1,613,590 control chromosomes in the GnomAD database, including 795 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 53 hom., cov: 30)
Exomes 𝑓: 0.029 ( 742 hom. )

Consequence

SLC5A5
NM_000453.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.46

Publications

7 publications found
Variant links:
Genes affected
SLC5A5 (HGNC:11040): (solute carrier family 5 member 5) This gene encodes a member of the sodium glucose cotransporter family. The encoded protein is responsible for the uptake of iodine in tissues such as the thyroid and lactating breast tissue. The iodine taken up by the thyroid is incorporated into the metabolic regulators triiodothyronine (T3) and tetraiodothyronine (T4). Mutations in this gene are associated with thyroid dyshormonogenesis 1.[provided by RefSeq, Sep 2009]
SLC5A5 Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 19-17888430-C-T is Benign according to our data. Variant chr19-17888430-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 328542.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.45 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0206 (3129/152040) while in subpopulation SAS AF = 0.0369 (177/4800). AF 95% confidence interval is 0.0324. There are 53 homozygotes in GnomAd4. There are 1474 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 53 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC5A5NM_000453.3 linkc.1626C>T p.Cys542Cys synonymous_variant Exon 13 of 15 ENST00000222248.4 NP_000444.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC5A5ENST00000222248.4 linkc.1626C>T p.Cys542Cys synonymous_variant Exon 13 of 15 1 NM_000453.3 ENSP00000222248.2
SLC5A5ENST00000597109.1 linkn.*52C>T downstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0206
AC:
3128
AN:
151926
Hom.:
53
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00544
Gnomad AMI
AF:
0.108
Gnomad AMR
AF:
0.0231
Gnomad ASJ
AF:
0.0450
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.0368
Gnomad FIN
AF:
0.00699
Gnomad MID
AF:
0.0478
Gnomad NFE
AF:
0.0289
Gnomad OTH
AF:
0.0302
GnomAD2 exomes
AF:
0.0245
AC:
6153
AN:
251280
AF XY:
0.0267
show subpopulations
Gnomad AFR exome
AF:
0.00369
Gnomad AMR exome
AF:
0.0128
Gnomad ASJ exome
AF:
0.0487
Gnomad EAS exome
AF:
0.000489
Gnomad FIN exome
AF:
0.00977
Gnomad NFE exome
AF:
0.0305
Gnomad OTH exome
AF:
0.0284
GnomAD4 exome
AF:
0.0288
AC:
42110
AN:
1461550
Hom.:
742
Cov.:
32
AF XY:
0.0296
AC XY:
21492
AN XY:
727084
show subpopulations
African (AFR)
AF:
0.00466
AC:
156
AN:
33480
American (AMR)
AF:
0.0134
AC:
599
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0474
AC:
1239
AN:
26136
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39692
South Asian (SAS)
AF:
0.0434
AC:
3745
AN:
86250
European-Finnish (FIN)
AF:
0.00995
AC:
530
AN:
53242
Middle Eastern (MID)
AF:
0.0492
AC:
284
AN:
5768
European-Non Finnish (NFE)
AF:
0.0302
AC:
33620
AN:
1111870
Other (OTH)
AF:
0.0320
AC:
1931
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
2237
4473
6710
8946
11183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1280
2560
3840
5120
6400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0206
AC:
3129
AN:
152040
Hom.:
53
Cov.:
30
AF XY:
0.0198
AC XY:
1474
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.00543
AC:
225
AN:
41474
American (AMR)
AF:
0.0230
AC:
351
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.0450
AC:
156
AN:
3468
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5172
South Asian (SAS)
AF:
0.0369
AC:
177
AN:
4800
European-Finnish (FIN)
AF:
0.00699
AC:
74
AN:
10590
Middle Eastern (MID)
AF:
0.0483
AC:
14
AN:
290
European-Non Finnish (NFE)
AF:
0.0289
AC:
1967
AN:
67992
Other (OTH)
AF:
0.0304
AC:
64
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
150
300
449
599
749
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0276
Hom.:
151
Bravo
AF:
0.0210
Asia WGS
AF:
0.0140
AC:
48
AN:
3478
EpiCase
AF:
0.0318
EpiControl
AF:
0.0324

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Thyroid dyshormonogenesis 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.22
DANN
Benign
0.45
PhyloP100
-2.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45602038; hg19: chr19-17999239; API